Anemia Effects and Management

18th Annual NATA Symposium

18th Annual NATA Symposium, Florence 2018The 18th Annual NATA Symposium on Patient Blood Management, Haemostasis and Thrombosis will take place at the Firenze Fiera Congress & Exhibition Center in Florence, Italy, on April 20-21, 2017.

The scientific programme is now online.

The extended deadline for abstract submission is January 15, 2017.

The second announcement can be downloaded here.

For more information, please visit the Events > Annual Symposium section.

More information about the 18th Annual NATA Symposium

News from the Industry: Monofer – a new therapeutic option for iron-deficiency anemia

Monofer® (iron isomaltoside 1000) is an innovative intravenous iron preparation that allows high-dose iron treatment for patients with iron-deficiency anemia. Monofer is indicated for the treatment of iron-deficiency anemia when oral iron preparations are ineffective or cannot be used, or when there is a clinical need to deliver iron rapidly.
For more information on Monofer, read the full article.

Read more on this


From the Literature

Mar 26, 2017

Published: Jan 2017

French CJ, Glassford NJ, Gantner D, et al.

Erythropoiesis-stimulating agents in critically ill trauma patients: a systematic review and meta-analysis.
Ann Surg 2017;265:54-62.

#

NATA REVIEW:
In this paper, French and co-authors address the ongoing debate on the use of erythropoietin (EPO) in critically...
REVIEW by:
C. So-Osman

Published: Nov 2016

von Heymann C, Kaufner L, Sander M, et al.

Does the severity of preoperative anemia or blood transfusion have a stronger impact on long-term survival after cardiac surgery?
J Thorac Cardiovasc Surg 2016;152:1412-1420.

#

NATA REVIEW:
In this study, von Heymann and colleagues describe the effects of different degrees of preoperative anaemia and/or...
REVIEW by:
J. Meier

Published: Oct 2016

Voorn VM, van der Hout A, So-Osman C, et al.

Erythropoietin to reduce allogeneic red blood cell transfusion in patients undergoing total hip or knee arthroplasty.
Vox Sang 2016;111:219-225.

#

NATA REVIEW:
The authors conducted a systematic review and meta-analysis to assess the benefits, the safety and the costs...
REVIEW by:
J.-F. Hardy

Published: Jul 2016

Jankowska EA, Tkaczyszyn M, Suchocki T, et al.

Effects of intravenous iron therapy in iron-deficient patients with systolic heart failure: a meta-analysis of randomized controlled trials.
Eur J Heart Fail 2016;18:786-795.

#

NATA REVIEW:
Iron deficiency has been observed in a large proportion of patients with chronic heart failure. Most importantly,...
REVIEW by:
D. Faraoni

Published: Jul 2016

Froessler B, Palm P, Weber I, Hodyl NA, Singh R, Murphy EM

The important role for intravenous iron in perioperative patient blood management in major abdominal surgery: a randomized controlled trial.
Ann Surg 2016;264:41-46.

#

NATA REVIEW:
In this study, patients with confirmed iron-deficiency anaemia (IDA) scheduled for major abdominal surgery (mostly...
REVIEW by:
M. Muñoz

Published: Jun 2016

Shuvy M, Mewa J, Wolff R, et al.

Preprocedure anemia management decreases transfusion rates in patients undergoing transcatheter aortic valve implantation.
Can J Cardiol 2016;32:732-738.

#

NATA REVIEW:
The authors sought to assess the impact of a preoperative blood conservation approach in treating anaemia and...
REVIEW by:
J.-F. Hardy